Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity - Summary of Stock Option Activity (Details)

v3.25.0.1
Stockholders' Equity - Summary of Stock Option Activity (Details) - USD ($)
$ / shares in Units, $ in Thousands
 6 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Options    
Options Outstanding, beginning balance 1,158,530 1,446,260
Options, Exercises (230,668) (178,128)
Options Outstanding, ending balance 927,862 1,268,132
Options, Exercisable 922,862 1,097,464
Weighted Average Exercise Price Per Share    
Weighted Average Exercise Price Per Share, Outstanding beginning balance $ 7.1 $ 7.11
Weighted Average Exercise Price Per Share, Exercised 14.23 5.95
Weighted Average Exercise Price Per Share, Outstanding ending balance 5.32 7.27
Weighted Average Exercise Price Per Share, Exercisable $ 5.14 $ 5.43
Aggregate Intrinsic Value, Outstanding beginning balance $ 29,354 $ 43,882
Aggregate Intrinsic Value, Exercises 6,828 5,056
Aggregate Intrinsic Value, Outstanding ending balance 20,607 29,234
Aggregate Intrinsic Value, Exercisable $ 20,607 $ 27,244
Weighted Average Grant Date Fair Value Per Award, Outstanding beginning balance [1] $ 3.53 $ 3.58
Weighted Average Grant Date Fair Value Per Award, Exercises [1] 6.56 3.58
Weighted Average Grant Date Fair Value Per Award, Outstanding ending balance [1] 2.78 3.58
Weighted Average Grant Date Fair Value Per Award, Exercisable [1] $ 2.7 $ 2.77
[1] The Company issued the options with an exercise price per share not less than the closing market price of common stock on the grant date.